[Results of phase I/II clinical trials of TGFbeta inhibitors in patients with glioblastoma suggest improved survival rates compared with conventional chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE